Please provide your email address to receive an email when new articles are posted on . The FDA has approved the expanded use area of Klisyri to up to 100 cm 2 on the face and scalp for the treatment ...

Sun Pharmaceutical Industries Limited (($IN:SUNPHARMA)) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Limited ...

Sun Pharmaceutical Industries Limited (($IN:SUNPHARMA)) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Limited ...

The approval was based on data from 2 multicenter, randomized, double-blind, phase 3 trials (ClinicalTrials.gov: NCT03285477 [N=351] and NCT03285490 [N=351]) that compared the efficacy and safety of ...

Actinic keratosis (AK) is a common precancerous lesion arising from cumulative ultraviolet exposure, often heralding the development of non-melanoma skin cancers such as basal cell carcinoma and ...

Please provide your email address to receive an email when new articles are posted on . Patients and clinicians agreed overall skin appearance and texture were improved with tirbanibulin treatment.

First-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis (AK) on the face or scalp with a 5-day application course Klisyri will be manufactured by Athenex Almirall ...

Dear Doctor K: I saw my doctor about a patch of rough, brown skin that I noticed on my upper arm. He said it is actinic keratosis and needs to be removed. Is it cancer? How will it be removed? Dear ...

- Actinic keratosis (AK), the second most common diagnosis made by dermatologists in the United States(1), affects more than 40 million Americans each year(2) - Klisyri® (tirbanibulin) met the primary ...

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the ...

Background Actinic keratosis (AK) is a UV-induced, premalignant skin condition that is common in adults over 60 years of age with fair skin in Scotland. The most commonly prescribed first-line ...